Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus ® (oral semaglutide) significantly ...

Rybelsus and Ozempic are prescribed to help manage blood sugar levels in adults with type 2 diabetes. Below are the dosages of each drug for this use. Strengths are listed in milligrams (mg ...

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with ...

Rybelsus ® reduced major adverse cardiovascular ... type 2 diabetes and chronic kidney disease 3. When combined, these conditions represent the leading cause of death globally 4.